Related Experiment Videos
[Surgery in ovarian carcinoma]
1Dept. of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|August 1, 1995
Summary
Surgery is crucial for ovarian cancer treatment. Reducing tumor size through cytoreductive surgery improves chemotherapy effectiveness and patient survival, especially in advanced stages.
Area of Science:
- Oncology
- Surgical Oncology
- Gynecologic Oncology
Context:
- Ovarian cancer spreads via exfoliated malignant cells throughout the peritoneal cavity.
- Surgical strategies are being developed based on disease spread patterns.
- Early-stage ovarian cancer surgery assesses disease extent.
Purpose:
- To establish stage-specific surgical operations for ovarian cancer.
- To evaluate the impact of cytoreductive surgery on treatment outcomes.
- To determine the relationship between residual tumor size and patient survival.
Summary:
- Cytoreductive surgery in advanced ovarian cancer reduces tumor bulk, enhancing chemotherapy sensitivity.
- Optimal tumor resection, aiming for residual disease <1 cm, significantly impacts survival.
- Even in suboptimal resections (>1 cm residual disease), smaller tumor size (<2 cm) correlates with longer survival.
Impact:
- Surgical principles align with cellular kinetics, supporting cytoreductive surgery benefits.
- Complete response to chemotherapy is associated with optimal or suboptimal tumor resection.
- Tailored surgical approaches improve patient outcomes in ovarian cancer management.